Quetiapine Fumarate

CAS 111974-72-2 29 API suppliersSmall Molecule

Overview

Quetiapine Fumarate is an atypical antipsychotic used in the treatment of schizophrenia, bipolar disorder, and major depressive disorder. It acts by antagonizing multiple neurotransmitter receptors in the brain, exhibiting effects on serotonin and dopamine systems.

API suppliers (30)

Suppliers of Quetiapine Fumarate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India11Spain5China4Italy3Netherlands1Hungary1Ukraine1

Country recorded for 26 of 30 suppliers.

19 of 30 hold a GMP certificate on record in the EU or UK registers · 1 holds a European CEP for this substance

Showing 25 of 30 suppliers — see the full list in the app.

Therapeutic areas

PsychiatryNeurology
Verified Supplier Partner

Do you supply Quetiapine Fumarate? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.